In this article, we will take a look at the 14 Quality Stocks with Highest Dividends.

Fidelity portfolio managers said it is hard to predict which stocks will lead in the coming year. Even so, they have identified a group of companies they believe are positioned to perform across different market conditions. These tend to be established blue-chip firms across a range of industries. They have shown resilience during periods of volatility and have the ability to grow earnings steadily over time.

Sammy Simnegar, manager of Fidelity Magellan Fund, explained that uncertainty has become a constant feature of the market. He suggested that higher-quality companies often hold up better in this kind of environment. He noted that there is no single definition of quality investing, as different managers focus on different traits. In his view, some of the key characteristics include strong brands, high barriers to entry, and experienced management teams. He also pointed out that the most reliable signal of quality is consistent and predictable earnings. He added that the traditional line between blue-chip and growth stocks has changed over time.

In the past, blue-chip companies were usually consumer staples businesses, such as beverage or household product firms. They were known for steady but modest growth, reliable dividends, and slightly above-average earnings expansion. At the same time, investors looking for higher growth often turned to smaller companies, aiming to identify businesses that could eventually develop into larger market leaders.

Given this, we will take a look at some of the quality stocks with the highest dividends.

Our Methodology:

For this list, we screened for companies with a market cap above $2 billion and identified dividend companies with strong dividend histories. From the group, we picked stocks with dividend yields above 3%, as of March 17. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

14. Consolidated Edison, Inc. (NYSE:ED)

Dividend Yield as of March 17: 3.07%

On March 12, JPMorgan raised its price recommendation on Consolidated Edison, Inc. (NYSE:ED) to $113 from $107. It reiterated an Underweight rating on the shares. The firm said it had updated its models across the North American utilities group.

On March 4, KeyBanc also raised its price objective on Consolidated Edison, moving it to $96 from $86, while maintaining an Underweight rating. The firm pointed to the company’s Q4 results and a detailed update that included 2026 guidance, a refreshed capital plan, long-term EPS CAGR expectations, and an updated financing plan. It noted that these were largely in line with what it had anticipated.

Earlier in February, the company announced a public offering of 7,000,000 common shares. As part of the forward sale agreement, the forward counterparty agreed to borrow shares from third parties and sell them to J.P. Morgan Securities LLC, which is acting as the underwriter for the offering. The underwriter may sell the shares through the New York Stock Exchange LLC, in the over-the-counter market, or through negotiated transactions, either at market prices or at agreed-upon prices.

Consolidated Edison, Inc. (NYSE:ED) is one of the largest investor-owned energy delivery companies in the United States. It offers a broad range of energy-related products and services through its subsidiaries.

13. Medtronic plc (NYSE:MDT)

Dividend Yield as of March 17: 3.22%

On March 10, Medtronic plc (NYSE:MDT) announced that it had agreed to acquire Scientia Vascular for about $550 million, with additional payments tied to future milestones.

Scientia is a private company based in Utah. It has developed specialized guidewires and catheters that help doctors move through complex brain blood vessels more easily. The technology is built to work alongside Medtronic’s existing neurovascular products. The deal is meant to strengthen Medtronic’s position in stroke and other neurovascular procedures. In these cases, doctors need fast and precise access to blocked or damaged vessels. That part is critical.

Linnea Burman, senior vice president and president of Medtronic’s Neurovascular business, which is part of the Neuroscience Portfolio at Medtronic, made the following comment:

“Medtronic is thrilled to acquire Scientia to accelerate meaningful innovation in neurovascular care. This acquisition positions Medtronic with a full suite of products. It builds a strong foundation for Medtronic and supports procedures across both hemorrhagic and acute ischemic stroke. Medtronic’s best-in-class therapies, combined with Scientia’s leading access portfolio, will be incredibly powerful. With 12 million people globally suffering from stroke each year, we look forward to contributing to better patient outcomes around the world.”

Brain vessels are complicated, and reaching the right spot can take time. Scientia’s tools are designed to improve navigation. This can make procedures faster and more efficient, which may help improve patient outcomes. The acquisition is expected to close in the first half of FY27, subject to regulatory approvals and other closing conditions. It is expected to be minimally dilutive to Medtronic adjusted EPS in FY27 and accretive thereafter.

Medtronic plc (NYSE:MDT) is based in Ireland and provides healthcare technology solutions.